Chione Ltd's Form 4 filing
Acrivon Therapeutics, Inc. (ACRV) · filed Jun 20, 2023
- Accession no.
- 0001213900-23-050160
- Filed
- Jun 20, 2023, 5:15 PM ET
- Trade date
- Jun 15, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $25.0K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chione LtdCIK 0001590232 | 10% Owner |
| Hadjimichael AndreasCIK 0001591256 | 10% Owner |
| Smolokowski WiaczeslawCIK 0001591274 | 10% Owner |
| Czernik MarcinCIK 0001591275 | 10% Owner |
| Nikolaou AnastasisCIK 0001954186 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2023 | Common Stock | SSaleDisposed | −2,056 | $12.14 | −$24,959.84 | 3,848,648 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.